JBM (Healthcare) Limited

SEHK:2161 Stock Report

Market Cap: HK$1.5b

JBM (Healthcare) Management

Management criteria checks 4/4

JBM (Healthcare)'s CEO is Patrick Wong, appointed in Sep 2020, has a tenure of 4.25 years. total yearly compensation is HK$2.39M, comprised of 91.7% salary and 8.3% bonuses, including company stock and options. directly owns 0.076% of the company’s shares, worth HK$1.14M. The average tenure of the management team and the board of directors is 2.7 years and 4.1 years respectively.

Key information

Patrick Wong

Chief executive officer

HK$2.4m

Total compensation

CEO salary percentage91.7%
CEO tenure4.3yrs
CEO ownership0.08%
Management average tenure2.7yrs
Board average tenure4.1yrs

Recent management updates

Recent updates

JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

Nov 08
JBM (Healthcare) Limited (HKG:2161) Stock Rockets 35% But Many Are Still Ignoring The Company

JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Dec 20
JBM (Healthcare)'s (HKG:2161) Earnings Are Weaker Than They Seem

Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

Nov 01
Here's Why JBM (Healthcare) (HKG:2161) Has Caught The Eye Of Investors

JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Jul 29
JBM (Healthcare) Limited's (HKG:2161) Shares May Have Run Too Fast Too Soon

Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Aug 03
Some Investors May Be Willing To Look Past JBM (Healthcare)'s (HKG:2161) Soft Earnings

Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

Jul 28
Estimating The Fair Value Of JBM (Healthcare) Limited (HKG:2161)

CEO Compensation Analysis

How has Patrick Wong's remuneration changed compared to JBM (Healthcare)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

HK$164m

Jun 30 2024n/an/a

HK$147m

Mar 31 2024HK$2mHK$2m

HK$130m

Dec 31 2023n/an/a

HK$114m

Sep 30 2023n/an/a

HK$98m

Jun 30 2023n/an/a

HK$78m

Mar 31 2023HK$3mHK$2m

HK$57m

Dec 31 2022n/an/a

HK$47m

Sep 30 2022n/an/a

HK$36m

Jun 30 2022n/an/a

HK$30m

Mar 31 2022HK$2mHK$2m

HK$25m

Dec 31 2021n/an/a

HK$18m

Sep 30 2021n/an/a

HK$11m

Jun 30 2021n/an/a

HK$17m

Mar 31 2021HK$2mHK$2m

HK$23m

Mar 31 2020HK$3mHK$2m

HK$41m

Compensation vs Market: Patrick's total compensation ($USD307.04K) is about average for companies of similar size in the Hong Kong market ($USD348.00K).

Compensation vs Earnings: Patrick's compensation has been consistent with company performance over the past year.


CEO

Patrick Wong (60 yo)

4.3yrs

Tenure

HK$2,386,000

Compensation

Mr. Yat Wai Wong is also known as Patrick, is the Chief Executive Director and Executive Director at JBM (Healthcare) Limited since September 22, 2020 and January 7, 2020 respectively. He joined JBM (Healt...


Leadership Team

NamePositionTenureCompensationOwnership
Yat Wai Wong
CEO & Executive Director4.3yrsHK$2.39m0.076%
HK$ 1.1m
Heung Kwan Cheng
Executive Directorless than a yearHK$12.00kno data
Kau Lap Lam
VP of Financeno datano datano data
Hoi Ki Leung
Operation Managerno datano datano data
Chui Yee Lo
Marketing Director5.8yrsno datano data
Chun Kau Yu
Company Secretary1.1yrsno datano data

2.7yrs

Average Tenure

53yo

Average Age

Experienced Management: 2161's management team is considered experienced (2.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yat Wai Wong
CEO & Executive Director4.9yrsHK$2.39m0.076%
HK$ 1.1m
Heung Kwan Cheng
Executive Directorless than a yearHK$12.00kno data
Chun Leung Yim
Non-Executive Director4.3yrsHK$353.00k1.6%
HK$ 23.9m
Kam Chiu Chan
Independent Non-Executive Director3.9yrsHK$196.00k0.0047%
HK$ 69.8k
Kwong Yip Sum
Non-Executive Chairman of the Board4.3yrsHK$10.84m23.34%
HK$ 349.6m
Kwok Chun Yeung
Non-Executive Director4.3yrsHK$196.00k0.047%
HK$ 698.3k
Ting Lung Luk
Independent Non-Executive Director3.9yrsHK$196.00kno data
Shut Lee Lau
Independent Non-Executive Director3.9yrsHK$196.00kno data

4.1yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 2161's board of directors are considered experienced (4.1 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:49
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JBM (Healthcare) Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiao Qin DouUOB Kay Hian Research Pte Ltd
Gigi CheukUOB Kay Hian Research Pte Ltd